LOGIN  |  REGISTER
Amneal Pharmaceuticals
Cue Biopharma

Syra Health to Participate in Several Upcoming Healthcare and Technology Conferences

July 03, 2024 | Last Trade: US$0.50 0.24 -32.30

CARMEL, Ind., July 3, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will participate in the following healthcare and technology conferences:

  • AI Governance Conference, July 11, in Carmel, Indiana. Syra Health utilizes AI as part of its proprietary suite of technology products. Syra Health is a sponsor of this conference and will share more about its dedication to the transparent, safe, and ethical use of AI.

  • Cric Indy's Community for Diversity, Equity & and Inclusion, Aug. 16-17. Several multinational companies will gather to discuss the event theme of "Connecting Communities and Celebrating Diversity." Syra Health is a sponsor and has also assembled a team to play cricket for the event.

  • Centene Supplier Summit, Aug. 20, in St. Louis, Missouri. Leaders and suppliers from around the country will meet to network and discuss growing business in the spirit of partnership and collaboration.

ABOUT SYRA HEALTH

Syra Health is a healthcare technology company powering better health in challenging areas such as behavioral and mental healthdigital health, and population health, by providing innovative services and technology products. Syra Health's offerings are centered on prevention, improved access, and affordable care. Syra Health serves everyone working in healthcare. For more information, visit www.syrahealth.com.

Contacts

For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health
463-345-5180
This email address is being protected from spambots. You need JavaScript enabled to view it.

For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
This email address is being protected from spambots. You need JavaScript enabled to view it.

Recursion

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page